The Association of Clinical Research Professionals (ACRP) today announces Ora, Inc. as the first corporate supporter of the Clinical Research Site Sustainability Fund.
Ora’s generous donation will allow ACRP to provide continuing education and career development resources through ACRP Membership to nearly 50 clinical research professionals working at clinical trial sites adversely impacted by the ongoing COVID-19 pandemic.
“Investigator sites and their teams are hurting. This is particularly true for sites engaged in ophthalmology studies,” says Jim Kremidas, ACRP Executive Director. “COVID-19 is disrupting site operations and threatening global capacity to conduct both private- and public-sponsored clinical trials. Many smaller sites are laying off or furloughing staff. At the same time, struggling sites are cutting budgets and programs that support staff development and make sure clinical operations teams are properly trained and ready to execute studies for sponsors and CROs. We are grateful for Ora’s considerable support, which will help ACRP ensure sites’ teams keep their skills honed and stay current with best practices – ready to keep medical progress moving.”
Ora’s donation will be directed to clinical researchers working in ophthalmology trials.
“During these challenging times it is important for us to reach out and help our partners. This will ensure the continuation of research and provide new care options for patients,” says Jeanne Hecht, CEO at Ora, Inc. “Joining forces with ACRP on this program was a perfect way to offer sites the support and resources they so greatly need. We remain fully committed to advancing and innovating in the field of ophthalmology, this is not possible without the hard work and dedication of our investigator sites and their teams.”
The Clinical Research Site Sustainability Fund is a new initiative of ACRP’s Partners in Workforce Advancement designed to support sites struggling with the impacts of COVID-19.
Partners in Workforce Advancement is a multi-stakeholder collaborative initiative to grow the clinical research workforce and to set and support standards for workforce competence.
Organizations interested in supporting the Clinical Research Site Sustainability Fund are encouraged to join ACRP’s Partners in Workforce Advancement (Click for Details >).
Individuals can also contribute to the fund through a special GoFundMe established to support this initiative (Click for Details >).
About Ora, Inc.
Ora is the world’s leading full-service ophthalmic drug and device development firm with offices in the United States, United Kingdom, Australia, and Asia. For over 40 years, we have proudly helped our clients earn more than 45 product approvals. We support a wide array of organizations, from start-ups to global pharmaceutical and device companies, to efficiently bring their new products from concept to market. Ora’s pre-clinical and clinical models, unique methodologies, and global regulatory strategies have been refined and proven across thousands of global projects. We bring together the world’s most extensive and experienced team of ophthalmic experts, R&D professionals, and management executives to maximize the value of new product initiatives. For more information, please visit https://www.oraclinical.com/.